Transformation of Arylmethylamines into R-Aminophosphonic Acids
J . Org. Chem., Vol. 65, No. 19, 2000 6129
desiccator over KOH. The crude product was purified by ion
exchange chromatogrphy (Dowex 50W x 4, H+, 50-100 mesh),
using water as eluent. Ninhydrin positive fractions were
pooled, concentrated by rotary evaporation to a small volume
and freeze-dried to leave a sufficiently pure, crystalline product
11 or 41. The analytical sample was crystallized from water.
Dieth yl N-P h en ylm eth ylp h osp h or a m id a te (14). Ben-
zylamine (5) (2.3 mL, 2.3 g, 22 mmol) yielded according to
general procedure A 4.40 g (90%) of phosphoramidate 14 as a
colorless liquid: bp 140 °C/0.15 mm (lit.16 bp 120 °C/0.05 mm).
mmol) gave by general procedure C 0.265 g (77%) of crystalline
(()-10c: Rf 0.15 (2:1 hexanes/EtOAc); mp 119-121 °C (hex-
anes) (lit.21 mp 118-120 °C).
(()-Diet h yl
1-(Diet h oxyp h osp h in yla m in o)p h en yl-
m eth ylph osph on ate [(()-10f]. Bisphosphoramidate 6f (0.380
g, 1 mmol) furnished by general procedure C 0.267 g (70%) of
(()-10f as a colorless oil: Rf 0.08 (1:8 CH2Cl2/EtOAc); IR (Si)
1240, 1029 cm-1; 1H NMR (250.1 MHz, CDCl3) δ 0.97 (dt, J )
0.9, 7.1 Hz, 3H), 1.03 (dt, J ) 0.7, 7.1 Hz, 3H), 1.19 (dt, J )
0.9, 7.1 Hz, 3H),1.26 (dt, J ) 0.6, 7.0 Hz, 3H), 3.60 (m, 2H),
3.88 (m, 5H), 4.07 (m, 2H), 4.44 (dt, J ) 10.6, 23.2 Hz, 1H),
7.30 (m, 5H); 13C NMR (100.6 MHz, CDCl3) δ 15.66 (d, J ) 7.7
Hz), 15.98 (d, J ) 7.6 Hz), 16.06 (d, J ) 6.1 Hz), 16.32 (d, J )
6.1 Hz), 52.98 (d, J ) 154.5 Hz), 62.34 (d, J ) 4.6 Hz), 62.39
(d, J ) 5.4 Hz), 62.97 (d, J ) 6.9 Hz), 63.26 (d, J ) 6.9 Hz),
127.79 (d, J ) 6.1 Hz, 2C), 128.00 (d, J ) 3.1 Hz), 128.37 (d,
J ) 2.3 Hz, 2C), 136.69.
Diet h yl N-4-Tolu en esu lfon yl-N-p h en ylm et h ylp h os-
p h or a m id a te (6b). Phosphoramidate 14 (1.2 g, 5 mmol)
yielded according to general procedure B 1.30 g (65%) of
tosylamide 6b as a colorless oil: Rf 0.64 (8:1 CH2Cl2/EtOAc);
IR (Si) 1353, 1268, 1020 cm-1; 1H NMR (250.1 MHz, CDCl3) δ
1.21 (dt, J ) 1.1, 7.0 Hz, 6H), 2.36 (s, 3H), 3.97 (m, 4H), 4.66
(d, J ) 11.4 Hz), 7.21 (m, 5H), 7.41 (m, 2H), 7.70 (m, 2H); 13
C
Rea ction of n -Bu Li/TMEDA w ith Tosyla ted P h osp h o-
r a m id a t e 6b : (()-Diet h yl 1-P h en ylp en t ylp h osp h on a t e
[(()-21]. Phosphoramidate 6b (397 mg, 1 mmol) was treated
with n-BuLi (2.4 mmol, 1.5 mL, 1.6 M solution in hexane)/
TMEDA (0.36 mL, 279 mg, 2.4 mmol) according to general
procedure C. Flash chromatography (1:1 hexanes/EtOAc; Rf
0.16) and bulb-to-bulb distillation (130-140 °C/0.3 mm) gave
217 mg (73%) of (()-21 as a colorless oil: IR (Si) 3209, 1232,
1033 cm-1; 1H NMR (250.1 MHz, CDCl3) δ 0.80 (t, J ) 6.9 Hz,
3H), 0.97 (dt, J ) 0.9, 7.1 Hz, 3H), 1.21 (m, 4H), 1.24 (dt, J )
0.9, 7.1 Hz, 3H), 1.68 (m, 2H), 3.38 (br.t, J ) 9.3 Hz, 1H), 3.54
(m, 1H), 3.81 (m, 1H), 3.98 (m, 3H), 7.22 (m, 5H); 13C NMR
(62.9 MHz, CDCl3) δ 13.62, 15.51 (d, J ) 7.8 Hz), 15.89 (d, J
) 7.4 Hz), 22.08, 28.03, 38.59 (d, J ) 7.4 Hz), 55.86, 61.64 (d,
J ) 4.6 Hz), 61.66 (d, J ) 5.1 Hz), 126.08 (2C), 126.71, 128.06
(2C), 144.22 (d, J ) 2.8 Hz). Anal. Calcd for C15H26NO3P
(299.35): C, 60.19; H, 8.75; N, 4.68. Found: C, 60.21; H, 8.70,
N, 4.46.
NMR (100.6 MHz, CDCl3) δ 15.52 (d, J ) 7.4 Hz), 21.13, 51.60
(d, J ) 2.3 Hz), 63.81 (d, J ) 5.5 Hz), 127.32, 127.54 (2C),
127.83 (2C), 128.43 (2C), 128.89 (2C), 136.40, 136.98, 143.65.
Anal. Calcd for C18H24NO5P (397.43): C, 54.40; H, 6.09; N,
3.52. Found: C, 54.66; H, 5.98, N, 3.42.
Dieth yl N-ter t-Bu toxyca r bon yl-N-p h en ylm eth ylp h os-
p h or a m id a te (6c). Meth od 1. A solution of s-BuLi (4.6 mL,
6.0 mmol, 1.3 M in cyclohexane) was added to a cooled (bath
temperature -40 °C) solution of N-Boc benzylamine (23)19
(1.04 g, 5 mmol) in dry toluene (10 mL) under argon. Stirring
was continued for 15 min. Diethyl chlorophosphate (0.87 mL,
1.04 g, 6.0 mmol, dissolved in 5 mL of dry toluene) was added.
The reaction mixture was allowed to warm slowly to room
temperature and was stirred until the starting material was
consumed (16 h, TLC: 8:1 CH2Cl2/EtOAc). CH2Cl2 and a
saturated solution of NH4Cl were added. The organic phase
was separated and the aqueous one was extracted twice with
CH2Cl2. The combined organic layers were washed with 0.5
M HCl and a saturated solution of NaHCO3, dried with Na2-
SO4 and concentrated in vacuo. The residue was flash chro-
matographed to yield 0.98 g (56%) of 6c as a viscous oil; Rf
0.57 (8:1 CH2Cl2/EtOAc).
Meth od 2. Phosphoramidate 14 (1.20 g, 5 mmol) was
transformed by general procedure B into 1.33 g (78%) of 6c as
a viscous oil: IR (Si) 1720 cm-1; 1H NMR (400.1 MHz, CDCl3)
δ 1.30 (dt, J ) 1.1, 7.0 Hz, 6H), 1.48 (s, 9H), 4.05 (m, 4H),
4.74 (d, J ) 11.2 Hz), 7.31 (m, 3H), 7.45 (m, 2H); 13C NMR
(100.6 MHz, CDCl3) δ 15.95 (d, J ) 6.9 Hz), 27.94, 49.49 (d, J
) 3.8 Hz), 63.26 (d, J ) 6.1 Hz), 82.30, 127.10, 127.99 (2C),
128.13 (2C), 138.85, 153.57 (d, J ) 6.1 Hz).
N-P h en ylm eth yl-2-d ieth oxyp h osp h in yl-4-m eth ylben -
zen esu lfon a m id e (22). N-Tosyl phosphoramidate 6b (0.40
g, 1 mmol) was treated with LDA according to general
procedure E. Flash chromatography (2:1 hexanes/EtOAc, Rf
0.35) of the crude product furnished 0.27 g (68%) of 22 as
crystalline solid: mp 78-80 °C (hexanes); IR (Si) 3142, 1021
1
cm-1; H NMR (250.1 MHz, CDCl3) δ 1.33 (t, J ) 0.7, 7.1 Hz,
6H), 2.41 (s, 3H), 4.07 (d, J ) 6.2 Hz, 2H), 4.17 (m, 4H), 7.14
(m, 5H), 7.37 (br.d, J ) 8.2 Hz, 1H), 7.66 (dd, J ) 1.4, 13.9
Hz, 1H), 7.95 (br.t, J ) 6.8 Hz), 7.99 (dd, J ) 6.2, 8.2 Hz, 1H);
13C NMR (62.9 MHz, CDCl3) δ 16.00 (d, J ) 6.4 Hz), 21.10,
47.16, 63.12 (d, J ) 5.5 Hz), 126.01 (d, J ) 187.1 Hz), 127.02,
127.67 128.02 (2C), 130.31 (d, J ) 12.4 Hz), 132.36 (d, J ) 2.8
Hz), 135.08 (d, J ) 6.0 Hz), 136.46, 140.73 (d, J ) 10.1 Hz),
Tet r a et h yl N-N-P h en ylm et h ylb is(p h osp h or a m id a t e)
(6f). Phosphoramidate 14 (1.20 g, 5 mmol) was transformed
by general procedure B into 1.34 g (72%) of 6f25 as a viscous
142.12 (d, J ) 12.9 Hz). Anal. Calcd for
C18H24NO5PS
(397.43): C, 54.40; H, 6.09; N, 3.52. Found: C, 54.63; H, 6.18,
N, 3.40.
1
oil: Rf 0.24 (1:3 CH2Cl2/EtOAc); IR (Si) 1262, 1026 cm-1; H
NMR (250.1 MHz, CDCl3) δ 1.22 (dt, J ) 0.6, 7.0 Hz, 12H),
3.99 (m, 8H), 4.52 (t, J ) 13.8 Hz, 2H), 7.25 (m, 3H), 7.49 (m,
2H); 13C NMR (100.6 MHz, CDCl3) δ 15.86 (d, J ) 3.1 Hz),
15.90 (d, J ) 3.1 Hz), 50.58, 63.23 (d, J ) 2.3 Hz), 63.27 (d, J
) 2.3 Hz), 127.38, 127.88 (2C), 128.83 (2C), 138.44.
Ca r boxyla tion a n d Rea r r a n gem en t of P h osp h or a m i-
d a te 14. s-BuLi (0.88 mL, 1.14 mmol, 1.3 M, in cyclohexane)
was added to a stirred and cooled (bath temperature -78 °C)
solution of phosphoramidate 14 (0.24 g, 1 mmol) in dry diethyl
ether (5 mL). After the solution was stirred for 5 min, the argon
atmosphere was replaced by a CO2 atmosphere, the cooling
bath was removed, and stirring was continued for 20 min. The
solvent was removed at the oil pump (0.3 mm), and the flask
was filled with argon. Dry diethy ether (5 mL) was added to
the residue, followed by s-BuLi (0.96 mL, 1.2 mmol, 1.3 M in
cyclohexane) after cooling of the solution to -78 °C. When the
reaction was complete (4 h, TLC 19:1 CH2Cl2/MeOH), AcOH
(1.15 mL, 2.3 mmol, 2 M solution in diethyl ether) was added.
The solvent was removed and the residue was diluted with
CH2Cl2 and water. The organic phase was separated and the
aqueous phase was extracted with CH2Cl2. The combined
organic layers were washed with water, dried (Na2SO4) and
concentrated in vacuo. The residue was flash chromatographed
(19:1 CH2Cl2/MeOH, Rf 0.29) to yield 115 mg (47%) of (()-27
as a colorless oil: 1H NMR (250.1 MHz, CDCl3) δ 1.16 (t, J )
7.0 Hz, 3H), 1.26 (t, J ) 7.3 Hz, 3H), 1.75 (br.s, 2H), 3.85 (m,
1H), 3.96 (m, 1H), 4.03 (m, 2H), 4.24 (d, J ) 17.1 Hz, 1H),
7.28 (m, 1H), 7.34 (m, 2H), 7.44 (m, 2H).
Diet h yl N-(1-Tr im et h ylsilylp h en ylm et h yl)p h osp h or -
a m id a te (16). Phosphoramidate 14 (243 mg, 1 mmol) fur-
nished according to general procedure D, except that Boc2O
was replaced by TMSCl and that the reaction mixture was
allowed to warm slowly at the end to room temperature, 0.252
g (80%) of (()-16 as a crystalline product: mp 78-79 °C
(hexanes); IR (Si) 1232, 1033 cm-1 1H NMR (250.1 MHz,
;
CDCl3) δ -0.02 (s, 9H), 0.85 (dt, J ) 0.9, 7.1 Hz, 3H), 1.27 (dt,
J ) 0.9, 7.1 Hz, 3H), 3.11 (br dd, J ) 10.1, 13.9 Hz, 1H), 3.47
(m, 1H), 3.66 (t, J ) 10.5 Hz, 2H); 3.79 (m, 1H), 3.99 (m, 2H),
7.09 (m, 3H), 7.23 (m, 2H); 13C NMR (62.9 MHz, CDCl3) δ
-4.01, 15.40 (d, J ) 7.8 Hz), 16.03 (d, J ) 7.4 Hz), 47.80 (d, J
) 5.1 Hz), 61.90 (d, J ) 4.6 Hz), 61.99 (d, J ) 5.1 Hz), 125.32,
125.83 (2C), 127.82 (2C), 142.82. Anal. Calcd for C14H24NO3-
PSi (315.42): C, 53.31; H, 7.67; N, 4.44. Found: C, 53.60; H,
7.96, N, 4.41.
(()-Dieth yl 1-(ter t-Bu toxyca r bon yla m in o)p h en ylm eth -
ylp h osp h on a t e [(()-10c]. Phosphoramidate 6c (0.34 g, 1